Objetivo
An ideal intervention in a chronic inflammatory disease such as Rheumatoid Arthritis (RA) would be a preventive one. In order to develop preventive strategies and therapies two key developments need to occur: (1) Biomarkers need to be identified that can be used to predict an individual’s risk of developing RA. (2) Modifiable disease mechanisms need to be identified and characterized in the early phases of disease. The key objective of the TEAM consortium is to specifically identify diagnostic biomarkers and disease mechanisms operating during the transition from health to rheumatoid arthritis. Our consortium will achieve this by developing a collaborative, integrated programme of work that links researchers with key SMEs involved in biomarker development to produce a “personalized predictive bioprofile” for patients destined to develop RA. The Euro-TEAM consortium will deliver a step change in the development of biomarkers and diagnostic kits that are timely, strategically important for European SMEs, and based on a disease (RA) in which concrete genetic and environmental risk factors have already been established. Firstly, it will directly compare biomarkers in the preclinical phases of disease with established markers in the clinical phases. Secondly, it will look beyond the synovium interrogating lymphoid, lung and periodontal tissue in a first-in-class approach to measuring systemic changes in the earliest phases of disease. Thirdly, it will place great emphasis on understanding why synovial inflammation resolves in some individuals and develop biomarkers of this “reverse” phase. Fourthly, it will explore a key cell type (stromal cells) that has been almost completely ignored in current biomarker studies. Finally, it will directly involve patients and other specialists, particularly from the fields of genetics, ethics and patient and public involvement in helping to visualize and communicate risk following a positive biomarker test.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2012-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-FP - Small or medium-scale focused research projectCoordinador
B15 2TT Birmingham
Reino Unido
Ver en el mapa
Participantes (15)
8006 ZURICH
Ver en el mapa
2333 ZA Leiden
Ver en el mapa
17177 Stockholm
Ver en el mapa
1105AZ Amsterdam
Ver en el mapa
1090 Wien
Ver en el mapa
LS2 9JT Leeds
Ver en el mapa
10117 Berlin
Ver en el mapa
G12 8QQ Glasgow
Ver en el mapa
91054 Erlangen
Ver en el mapa
M13 9PL Manchester
Ver en el mapa
100 44 Stockholm
Ver en el mapa
La participación finalizó
1105 BA Amsterdam
Ver en el mapa
55129 MAINZ
Ver en el mapa
101 Reykjavik
Ver en el mapa
751 05 Uppsala
Ver en el mapa